Concepedia
Statistics
Publications
24
Citations
785
H-Index
16
Active since
2004
Affiliations
Fujian Medical University(Current)
Beth Israel Deaconess Medical Center
Cancer Research Institute
Translational Therapeutics (United States)
Sichuan University
Hekun Liu is an author at Fujian Medical University specializing in medicine, oncology, and molecular oncology.
Publications per year
2004–2023
Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway
Jichuang Wang, Nan Zhang, Qi Han et al. · Cancer Letters · 2018 · 109 citations
Medicine, Oncology, Pharmacology +16
A novel controlled release formulation of the Pin1 inhibitor ATRA to improve liver cancer therapy by simultaneously blocking multiple cancer pathways
Dayun Yang, Wensong Luo, Jichuang Wang et al. · Journal of Controlled Release · 2017 · 75 citations · Full text
Pharmacy, Oncology, Pharmacology +16
MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways
Xingxue Yan, Zhendong Zhu, Shenmin Xu et al. · Scientific Reports · 2017 · 57 citations · Full text
Medicine, Cancer Biology, Oncology +17
Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese
Hekun Liu, Sizhong Zhang, Jianyin Lin et al. · Metabolism · 2005 · 56 citations
Medicine, Genetics, Molecular Genetics +16
Chemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathways
Xin-Hua Liao, Arina Li Zhang, Min Zheng et al. · Scientific Reports · 2017 · 53 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 24